Picture: Aurobac

Aurobac Therapeutics has appointed Florence Séjourné as CEO. The French company is a joint venture, founded by Boehringer Ingelheim, Evotec and bioMérieux and focuses on combating antimicrobial resistance (AMR).

Biotech cluster Vienna

Takeda, Boehringer Ingelheim and Novartis do it repeatedly. Global players make ­major investments in their Austrian facilities. Not only multinationals but start-ups and scale-ups such as ­Apeiron Biologics and ViraTherapeutics benefit from a comprehensive ecosystem – from basic research to production and distribution. The business location agency ABA is the first point of contact for setting up operations in Austria.

Adv_11_22_Eppendorf.png

Eppendorf Tubes® BioBased reduce the product-specific carbon footprint and ­support environmental friendly lab workflow.

Memo Therapeutics used its huMemoMAB platform to develop antibodies to treat cancers and infections. © Memo Therapeutics AG

Antibody developer Memo Therapeutics AG has snaged a R&D partnership with Ono Pharmaceutical Co. Ltd in the immuno-oncology field.

The L130 Laboratory Refrigerator is used worldwide to store temperature-sensitive biologicals. Picture: © B Medical Systems

Keeping biologicals at low temperatures is an established and effective way of maintaining their potency. This is critical for many types of medicines, vaccines, reagents, and biological samples, which is the reason why laboratories, hospitals, clinics, pharmacies, and more employ medical-grade refrigerators to protect their samples from ambient conditions.

Natàlia Mas (ACCIÓ), Robert Fabregat (Biocat), Jaume Amat (CataloniaBio & HealthTech) and Silvia Ondategui (EY), today during the presentation of the 2021 BioRegion Report. © Biocat

Catalonia’s healthcare start-ups raised €238m in 2021, a new record and 4% up from 2020. Four fifth (83%) of VC came from international investors.
   

EU Health Commissioner Stella Kyriakides, archive photo. © European Parliament

The European Council has adopted three regulations aimed at improving pandemic preparedness, which together with two other pillars complete the EU Health Union.

Audi and Krajete aim at create sustainable next-generation technologies. © AUDI AG

Automotive company Audi AG and gas fermentation specialist Krajete GmbH are building a highly effective industrial-scale CO2 Direct Air Capturing plant in Linz.

Co-founder & managing directors: Dr Moritz Völker-Albert & Dr Victor Solis (left)

With its strategic location on the Martinsried campus, the IZB offers an outstanding opportunity to found a company in the vicinity of science and industry.

Marinosolv enables safe and stable solubilization of even highly hydrophobic substances.

Therapies for autoreactive immune disorders have greatly advanced in the past decades but often have significant side effects. Marinomed Biotech AG strives to improve therapies by increasing the solubility and bioavailability of existing drugs. A proprietary pipeline and Solv4U, a B2B offering for API solubilization, enable the development of clinically meaningful new or improved therapies.